Literature DB >> 26390983

Colibactin: understanding an elusive gut bacterial genotoxin.

Emily P Balskus1.   

Abstract

This highlight provides an overview of recent progress towards elucidating the structure, biosynthesis, and mode of action of colibactin, a genotoxic secondary metabolite synthesized by human gut bacteria. While isolating colibactin has been problematic, efforts to characterize its biosynthesis have provided critical information that has led to a rapid increase in our knowledge of this metabolite's structure and function. Major questions and gaps remain however, and the broader lessons learned from studying colibactin underscore central challenges to be faced in the genomics era of natural product research and in efforts to understand the human microbiome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26390983     DOI: 10.1039/c5np00091b

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  38 in total

Review 1.  Signaling Natural Products from Human Pathogenic Bacteria.

Authors:  Zhijuan Hu; Wenjun Zhang
Journal:  ACS Infect Dis       Date:  2019-10-30       Impact factor: 5.084

2.  Model Colibactins Exhibit Human Cell Genotoxicity in the Absence of Host Bacteria.

Authors:  Emilee E Shine; Mengzhao Xue; Jaymin R Patel; Alan R Healy; Yulia V Surovtseva; Seth B Herzon; Jason M Crawford
Journal:  ACS Chem Biol       Date:  2018-11-20       Impact factor: 5.100

Review 3.  Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer.

Authors:  Aurélie Gagnaire; Bertrand Nadel; Didier Raoult; Jacques Neefjes; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2017-01-03       Impact factor: 60.633

Review 4.  Natural product discovery from the human microbiome.

Authors:  Matthew R Wilson; Li Zha; Emily P Balskus
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

5.  Structure and Functional Analysis of ClbQ, an Unusual Intermediate-Releasing Thioesterase from the Colibactin Biosynthetic Pathway.

Authors:  Naga Sandhya Guntaka; Alan R Healy; Jason M Crawford; Seth B Herzon; Steven D Bruner
Journal:  ACS Chem Biol       Date:  2017-09-08       Impact factor: 5.100

Review 6.  Employing chemical synthesis to study the structure and function of colibactin, a "dark matter" metabolite.

Authors:  Peyton C Williams; Kevin M Wernke; Alina Tirla; Seth B Herzon
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

Review 7.  Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective.

Authors:  Alan R Healy; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2017-10-12       Impact factor: 15.419

Review 8.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

9.  In Vitro Characterization of the Colibactin-Activating Peptidase ClbP Enables Development of a Fluorogenic Activity Probe.

Authors:  Matthew R Volpe; Matthew R Wilson; Carolyn A Brotherton; Ethan S Winter; Sheila E Johnson; Emily P Balskus
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

Review 10.  Accessing Bioactive Natural Products from the Human Microbiome.

Authors:  Aleksandr Milshteyn; Dominic A Colosimo; Sean F Brady
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.